Trials / Completed
CompletedNCT05759936
4-week Seaweed Supplementation on Menopause Symptoms and Psychological Wellbeing
Effects of 4-week Seaweed Supplementation on Menopause Symptoms and Psychological Wellbeing - a Randomised, Placebo-controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Northumbria University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
Menopausal symptoms have a substantial effect on quality of life as well as potentially serving as markers for future health. Previous research has suggested that diet can impact menopausal symptoms. Seaweed is marketed as a treatment to alleviate menopause symptoms, but no research has tested whether it is effective in reducing the symptoms and psychological effects associated with menopause. The aim of this study is to investigate the effects of consuming a seaweed supplement over a 4-week time period on menopausal symptoms and psychological well-being.
Detailed description
Menopause and peri-menopause are associated with a number of symptoms and psychological well-being. Previous literature has found a relationship between diet and menopause management. For example, following the Mediterranean diet consuming a variety of vegetables, fruits, legumes and whole grains has found to improve menopausal symptoms particularly vasomotor symptoms. Few studies have explored the effects of dietary supplements on psychological well-being in menopause. The aim of the study is to explore the impact of an iodine-rich seaweed food supplement on menopause symptoms and mental well-being in those experiencing menopause. Online assessments of symptoms will take place pre-intervention and post-intervention and will be compared to the effects of a placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 500mg seaweed | 4 week supplementation of 1 capsule per day of seaweed |
| OTHER | Placebo | 4 week placebo supplement of 1 capsule per day |
Timeline
- Start date
- 2023-03-20
- Primary completion
- 2023-12-12
- Completion
- 2023-12-12
- First posted
- 2023-03-08
- Last updated
- 2024-03-21
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05759936. Inclusion in this directory is not an endorsement.